Amplify Weight Loss Drug & Treatment ETF (THNR)
NYSEARCA: THNR · Real-Time Price · USD
23.91
-0.06 (-0.26%)
Apr 28, 2026, 4:00 PM EDT - Market closed
THNR Holdings List
As of Apr 23, 2026
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | NVO | Novo Nordisk A/S | 13.48% |
| 2 | LLY | Eli Lilly and Company | 11.25% |
| 3 | REGN | Regeneron Pharmaceuticals, Inc. | 6.67% |
| 4 | AMGN | Amgen Inc. | 6.21% |
| 5 | TYO: 4519 | Chugai Pharmaceutical Co., Ltd. | 6.14% |
| 6 | ARWR | Arrowhead Pharmaceuticals, Inc. | 5.85% |
| 7 | HKG: 1801 | Innovent Biologics, Inc. | 5.27% |
| 8 | SWX: ROP | Roche Holding AG | 5.03% |
| 9 | HKG: 1093 | CSPC Pharmaceutical Group Limited | 4.97% |
| 10 | PFE | Pfizer Inc. | 4.94% |
| 11 | LON: AZN | AstraZeneca PLC | 4.85% |
| 12 | MRK | Merck & Co., Inc. | 4.75% |
| 13 | TYO: 4507 | Shionogi & Co., Ltd. | 4.36% |
| 14 | ABBV | AbbVie Inc. | 4.34% |
| 15 | SRRK | Scholar Rock Holding Corporation | 2.24% |
| 16 | VKTX | Viking Therapeutics, Inc. | 2.22% |
| 17 | GPCR | Structure Therapeutics Inc. | 1.90% |
| 18 | CPH: ZEAL | Zealand Pharma A/S | 1.83% |
| 19 | JNGHF | Jiangsu Hengrui Pharmaceuticals Co Ltd Ordinary Shares - Class H | 1.31% |
| 20 | KRX: 128940 | Hanmi Pharm. Co., Ltd. | 1.27% |
| 21 | AGPXX | Short-Term Investment Trust - Invesco Government & Agency Portfolio | 0.95% |
| 22 | n/a | OTHER ASSETS AND LIABILITIES | 0.16% |
As of Apr 23, 2026